First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation. The FINESS Trial Investigators
Y Almagor,
S Feld,
F Kiemeneij,
PW Serruys,
MC Morice,
A Colombo,
C Macaya,
JL Guermonprez,
J Marco,
R Erbel,
IM Penn,
R Bonan,
and
MB Leon
Shaare Zedek Medical Center, Jerusalem, Israel. cardio@szmc.org.il
OBJECTIVES: The purpose of this study was to determine the feasibility, safety and efficacy of elective and urgent deployment of the new intravascular rigid-flex (NIR) stent in patients with coronary artery disease. BACKGROUND: Stent implantation has been shown to be effective in the treatment of focal, new coronary stenoses and in restoring coronary flow after coronary dissection and abrupt vessel closure. However, currently available stents either lack flexibility, hindering navigation through tortuous arteries, or lack axial strength, resulting in suboptimal scaffolding of the vessel. The unique transforming multicellular design of the NIR stent appears to provide both longitudinal flexibility and radial strength. METHODS: NIR stent implantation was attempted in 255 patients (341 lesions) enrolled prospectively in a multicenter international registry from December 1995 through March 1996. Nine-, 16- and 32-mm long NIR stents were manually crimped onto coronary balloons and deployed in native coronary (94%) and saphenous vein graft (6%) lesions. Seventy-four percent of patients underwent elective stenting for primary or restenotic lesions, 21% for a suboptimal angioplasty result and 5% for threatened or abrupt vessel closure. Fifty-two percent of patients presented with unstable angina, 48% had a previous myocardial infarction, and 45% had multivessel disease. Coronary lesions were frequently complex, occurring in relatively small arteries (mean [+/-SD] reference diameter 2.8 +/- 0.6 mm). Patients were followed up for 6 months for the occurrence of major adverse cardiovascular events. RESULTS: Stent deployment was accomplished in 98% of lesions. Mean minimal lumen diameter increased by 1.51 +/- 0.51 mm (from 1.09 +/- 0.43 mm before to 2.60 +/- 0.50 mm after the procedure). Mean percent diameter stenosis decreased from 61 +/- 13% before to 17 +/- 7% after intervention. A successful interventional procedure with < 50% diameter stenosis of all treatment site lesions and no major adverse cardiac events within 30 days occurred in 95% of patients. Event-free survival at 6 months was 82%. Ninety-four percent of surviving patients were either asymptomatic or had mild stable angina at 6 month follow-up. CONCLUSIONS: Despite unfavorable clinical and angiographic characteristics of the majority of patients enrolled, the acute angiographic results and early clinical outcome after NIR stent deployment were very promising. A prospective, randomized trial comparing the NIR stent with other currently available stents appears warranted.
This article has been cited by other articles:

|
 |

|
 |
 
C. Hage, A. Norhammar, L. Grip, K. Malmberg, N. Sarkar, B. Svane, and L. Ryden
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study
Diabetes and Vascular Disease Research,
April 1, 2009;
6(2):
71 - 79.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Oemrawsingh, G. S. Mintz, M. J. Schalij, A. H. Zwinderman, J. W. Jukema, and E. E.v.d. Wall
Intravascular Ultrasound Guidance Improves Angiographic and Clinical Outcome of Stent Implantation for Long Coronary Artery Stenoses: Final Results of a Randomized Comparison With Angiographic Guidance (TULIP Study)
Circulation,
January 7, 2003;
107(1):
62 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Cantor, E. D. Peterson, J. J. Popma, J. P. Zidar, M. H. Sketch Jr., J. E. Tcheng, and E. M. Ohman
Provisional stenting strategies: systematic overview and implications for clinical decision-making
J. Am. Coll. Cardiol.,
October 1, 2000;
36(4):
1142 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. ROBERTS and S. W. REDDING
CORONARY ARTERY STENTS: REVIEW AND PATIENT-MANAGEMENT RECOMMENDATIONS
J Am Dent Assoc,
June 1, 2000;
131(6):
797 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kobayashi, J. De Gregorio, N. Kobayashi, T. Akiyama, B. Reimers, L. Finci, C. Di Mario, and A. Colombo
Stented segment length as an independent predictor of restenosis
J. Am. Coll. Cardiol.,
September 1, 1999;
34(3):
651 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C di Mario, B Reimers, Y Almagor, I Moussa, L Di Francesco, M Ferraro, M B Leon, K Richter, and A Colombo
Procedural and follow up results with a new balloon expandable stent in unselected lesions
Heart,
March 1, 1998;
79(3):
234 - 241.
[Abstract]
[Full Text]
|
 |
|
|